Search Results 261-270 of 17198 for hypercoagulable
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The purpose of this study is to collect and review the Mayo Clinic experience with left cardiac sympathetic denervation (LCSD) in patients with heritable ...
Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...
A blood clot blocks and stops blood flow to an artery in the lung. Often the clot starts in a leg and travels to the lung.
About this study. The purpose of this study is to assess the combination of INCMGA00012 with radiation therapy (RT) and bevacizumab with or without ...
About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20428726. Home; Gene Guide Ferber ...
Monoclonal antibodies, such as atezolizumab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such ...
Direct oral anticoagulants significantly decrease recurrent venous thrombosis for adult cancer patients, Mayo Clinic study · Research · Lifestyle changes can be ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Early Diagnosis and Teamwork Cures Intractable Epilepsy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.